Navigation

NEWS RELEASES

Search all of our news releases here.

Search
Generic filters

Try these: Jeff GalvinHIVFDAAmerican Gene Technologies

American Gene Technologies Announces Collaboration with GeoVax for HIV cure

Mar 14, 2017

Clinical Trial Expected to Commence in 2017   Rockville, MD, March 14, 2017 American Gene Technologies International Inc. (“AGT“) – announced today its collaboration with GeoVax Labs, Inc. (OTCQB: GOVX) for the conduct of a Phase 1 clinical trial investigating AGT’s viral vector technology as a functional… [Read More]

AGT’s CEO to Present at the 19th BIO CEO & Investor Conference

Feb 3, 2017

Rockville, MD American Gene Technologies (AGT), a gene technology company with a broad, robust lentiviral delivery platform, announced today that the CEO, Jeff Galvin is presenting at the upcoming BIO CEO & Investor conference. The Conference is being held on February 13 -14, at the… [Read More]

AGT’s CEO to Present at NobleCon13

Jan 27, 2017

View: 1.27.16 Press Release – NobleCon13 View: Noble Conference – Investor Presentation View: Webcast

Internationally Recognized Molecular Researcher Joins American Gene Technologies as Collaborator

Oct 4, 2016

ROCKVILLE, MARYLAND (October 4, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Dr. John J. Rossi, PhD as a collaborator on gene therapy research. Dr. Rossi is a leader in the field of molecular biology and a pioneer in the… [Read More]

Merv Turner to Chair American Gene Technologies’ Scientific Advisory Board

Jun 7, 2016

RENOWNED PHARMACEUTICAL STRATEGIST, MERV TURNER SEES GREAT PROMISE IN AGT’S EMERGING GENE THERAPY AND JOINS MANAGEMENT TO HELP GUIDE PRODUCTS TO COMMERCIALIZATION ROCKVILLE, MARYLAND (June 7, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Dr. Mervyn Turner as chairman of… [Read More]

Leading Healthcare Innovator Joins Board of Directors of American Gene Technologies

May 24, 2016

ADDITION OF JONATHAN OTTERSTATTER SIGNALS ADDITIONAL MOMENTUM FOR GENE THERAPY PIONEERS ROCKVILLE, MARYLAND (May 24, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Jonathan (Jon) Otterstatter to its board of directors. Otterstatter is co-founder, president and CEO of Preventice, Inc.,… [Read More]

AGT Announces Collaboration with Internationally Recognized Leader in Medical Genetics

May 13, 2016

JERRY VOCKLEY, MD, PHD COLLABORATES WITH AGT ON PHENYLKETONURIA (PKU) ROCKVILLE, Maryland. (May 13, 2016) – American Gene Technologies International, Inc. (AGT) today announced its collaboration with Jerry Vockley, MD, PhD, chief of the Division of Medical Genetics at Children’s Hospital of Pittsburgh of the University… [Read More]

American Gene Technologies Welcomes Visionary Leader to Board of Directors

Jan 27, 2016

ROCKVILLE, Md. (January 27, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Stuart B. Baker, MD to its board of directors. The latest addition to the emerging biotech’s roster of world-renowned experts comes on the heels of the addition of… [Read More]

Subscribe to News Releases and News Updates

Subscribe to our news release and published article updates to be notified when we release new content!

Follow AGT on Social Media